Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma

Name: Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
License: Public Domain

Second Affiliated Hospital, School of Medicine, Zhejiang University

ClinicalTrials.gov · Datasets · License: Public Domain

advanced cholangiocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 180384
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.